Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 23412777)

  • 1. Glioblastoma with oligodendroglial component represents a subgroup of glioblastoma with high prevalence of IDH1 mutation and association with younger age.
    Ha SY; Kang SY; Do IG; Suh YL
    J Neurooncol; 2013 May; 112(3):439-48. PubMed ID: 23412777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary glioblastoma with oligodendroglial differentiation has better clinical outcome but no difference in common biological markers compared with other types of glioblastoma.
    Laxton RC; Popov S; Doey L; Jury A; Bhangoo R; Gullan R; Chandler C; Brazil L; Sadler G; Beaney R; Sibtain N; King A; Bodi I; Jones C; Ashkan K; Al-Sarraj S
    Neuro Oncol; 2013 Dec; 15(12):1635-43. PubMed ID: 24158110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glioblastoma with an oligodendroglioma component: distinct clinical behavior, genetic alterations, and outcome.
    Wang Y; Li S; Chen L; You G; Bao Z; Yan W; Shi Z; Chen Y; Yao K; Zhang W; Kang C; Jiang T
    Neuro Oncol; 2012 Apr; 14(4):518-25. PubMed ID: 22326863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term survivors in glioblastomas with oligodendroglioma component: a clinical study of 186 Chinese patients from a single institution.
    Jiang H; Ren X; Wang J; Zhang Z; Jia W; Lin S
    J Neurooncol; 2014 Jan; 116(2):395-404. PubMed ID: 24264532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Relevance of Histomolecular Classification of Diffuse Adult High-Grade Gliomas with Necrosis.
    Figarella-Branger D; Mokhtari K; Colin C; Uro-Coste E; Jouvet A; Dehais C; Carpentier C; Villa C; Maurage CA; Eimer S; Polivka M; Vignaud JM; Laquerriere A; Sevestre H; Lechapt-Zalcman E; Quintin-Roué I; Aubriot-Lorton MH; Diebold MD; Viennet G; Adam C; Loussouarn D; Michalak S; Rigau V; Heitzmann A; Vandenbos F; Forest F; Chiforeanu D; Tortel MC; Labrousse F; Chenard MP; Nguyen AT; Varlet P; Kemeny JL; Levillain PM; Cazals-Hatem D; Richard P; Delattre JY;
    Brain Pathol; 2015 Jul; 25(4):418-28. PubMed ID: 25407774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glioblastoma with oligodendroglioma component (GBM-O): molecular genetic and clinical characteristics.
    Appin CL; Gao J; Chisolm C; Torian M; Alexis D; Vincentelli C; Schniederjan MJ; Hadjipanayis C; Olson JJ; Hunter S; Hao C; Brat DJ
    Brain Pathol; 2013 Jul; 23(4):454-61. PubMed ID: 23289977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognosis of Glioblastoma With Oligodendroglioma Component is Associated With the IDH1 Mutation and MGMT Methylation Status.
    Myung JK; Cho HJ; Kim H; Park CK; Lee SH; Choi SH; Park P; Yoon JM; Park SH
    Transl Oncol; 2014 Dec; 7(6):712-9. PubMed ID: 25500080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glioblastomas with IDH1/2 mutations have a short clinical history and have a favorable clinical outcome.
    Ohno M; Narita Y; Miyakita Y; Matsushita Y; Arita H; Yonezawa M; Yoshida A; Fukushima S; Takami H; Ichimura K; Shibui S
    Jpn J Clin Oncol; 2016 Jan; 46(1):31-9. PubMed ID: 26603354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IDH1 mutation of gliomas with long-term survival analysis.
    Myung JK; Cho HJ; Park CK; Kim SK; Phi JH; Park SH
    Oncol Rep; 2012 Nov; 28(5):1639-44. PubMed ID: 22922798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glioblastomas with an oligodendroglial component: a pathological and molecular study.
    He J; Mokhtari K; Sanson M; Marie Y; Kujas M; Huguet S; Leuraud P; Capelle L; Delattre JY; Poirier J; Hoang-Xuan K
    J Neuropathol Exp Neurol; 2001 Sep; 60(9):863-71. PubMed ID: 11556543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IDH1 mutations is prognostic marker for primary glioblastoma multiforme but MGMT hypermethylation is not prognostic for primary glioblastoma multiforme.
    Kalkan R; Atli Eİ; Özdemir M; Çiftçi E; Aydin HE; Artan S; Arslantaş A
    Gene; 2015 Jan; 554(1):81-6. PubMed ID: 25455102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characteristics of glioblastoma with 1p/19q co-deletion.
    Mizoguchi M; Yoshimoto K; Ma X; Guan Y; Hata N; Amano T; Nakamizo A; Suzuki SO; Iwaki T; Sasaki T
    Brain Tumor Pathol; 2012 Jul; 29(3):148-53. PubMed ID: 22736234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FISH 1p/19q deletion/imbalance for molecular subclassification of glioblastoma.
    Nagasaka T; Gunji M; Hosokai N; Hayashi K; Ikeda H; Ito M; Inao S
    Brain Tumor Pathol; 2007; 24(1):1-5. PubMed ID: 18095137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glioblastoma multiforme with oligodendroglial component (GBMO): favorable outcome after post-operative radiotherapy and chemotherapy with nimustine (ACNU) and teniposide (VM26).
    Vordermark D; Ruprecht K; Rieckmann P; Roggendorf W; Vince GH; Warmuth-Metz M; Kölbl O; Flentje M
    BMC Cancer; 2006 Oct; 6():247. PubMed ID: 17049083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular predictors of progression-free and overall survival in patients with newly diagnosed glioblastoma: a prospective translational study of the German Glioma Network.
    Weller M; Felsberg J; Hartmann C; Berger H; Steinbach JP; Schramm J; Westphal M; Schackert G; Simon M; Tonn JC; Heese O; Krex D; Nikkhah G; Pietsch T; Wiestler O; Reifenberger G; von Deimling A; Loeffler M
    J Clin Oncol; 2009 Dec; 27(34):5743-50. PubMed ID: 19805672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular prognostic factors of anaplastic oligodendroglial tumors and its relationship: a single institutional review of 77 patients from China.
    Li S; Yan C; Huang L; Qiu X; Wang Z; Jiang T
    Neuro Oncol; 2012 Jan; 14(1):109-16. PubMed ID: 22039037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Farewell to GBM-O: Genomic and transcriptomic profiling of glioblastoma with oligodendroglioma component reveals distinct molecular subgroups.
    Hinrichs BH; Newman S; Appin CL; Dunn W; Cooper L; Pauly R; Kowalski J; Rossi MR; Brat DJ
    Acta Neuropathol Commun; 2016 Jan; 4():4. PubMed ID: 26757882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glioblastomas with oligodendroglial component - common origin of the different histological parts and genetic subclassification.
    Klink B; Schlingelhof B; Klink M; Stout-Weider K; Patt S; Schrock E
    Anal Cell Pathol (Amst); 2010; 33(1):37-54. PubMed ID: 20966543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pediatric glioblastoma with oligodendroglioma component: aggressive clinical phenotype with distinct molecular characteristics.
    Mizoguchi M; Hata N; Suzuki SO; Fujioka Y; Murata H; Amano T; Nakamizo A; Yoshimoto K; Iwaki T; Sasaki T
    Neuropathology; 2013 Dec; 33(6):652-7. PubMed ID: 23530875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glioblastomas with oligodendroglial component-common origin of the different histological parts and genetic subclassification.
    Klink B; Schlingelhof B; Klink M; Stout-Weider K; Patt S; Schrock E
    Cell Oncol (Dordr); 2011 Jun; 34(3):261-75. PubMed ID: 21538026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.